A detailed history of Invesco Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 164,024 shares of HRMY stock, worth $5.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
164,024
Previous 150,934 8.67%
Holding current value
$5.59 Million
Previous $4.55 Million 43.91%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.0 - $39.95 $392,700 - $522,945
13,090 Added 8.67%
164,024 $6.55 Million
Q2 2024

Aug 13, 2024

BUY
$28.81 - $33.01 $490,519 - $562,028
17,026 Added 12.71%
150,934 $4.55 Million
Q1 2024

May 14, 2024

BUY
$29.93 - $35.06 $590,578 - $691,803
19,732 Added 17.28%
133,908 $4.5 Million
Q4 2023

Feb 12, 2024

SELL
$19.2 - $33.78 $235,526 - $414,379
-12,267 Reduced 9.7%
114,176 $3.69 Million
Q3 2023

Nov 13, 2023

SELL
$31.89 - $39.03 $669,243 - $819,083
-20,986 Reduced 14.23%
126,443 $4.14 Million
Q2 2023

Aug 11, 2023

SELL
$30.5 - $37.4 $24.6 Million - $30.2 Million
-806,902 Reduced 84.55%
147,429 $5.19 Million
Q1 2023

May 12, 2023

SELL
$30.8 - $53.92 $22.2 Million - $38.9 Million
-721,445 Reduced 43.05%
954,331 $31.2 Million
Q4 2022

Feb 13, 2023

BUY
$45.4 - $60.91 $23 Million - $30.8 Million
506,041 Added 43.26%
1,675,776 $92.3 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $38.3 Million - $50.4 Million
909,677 Added 349.8%
1,169,735 $51.8 Million
Q2 2022

Aug 15, 2022

BUY
$33.54 - $52.15 $1.94 Million - $3.01 Million
57,750 Added 28.55%
260,058 $12.7 Million
Q1 2022

May 16, 2022

BUY
$33.14 - $51.13 $3.05 Million - $4.7 Million
91,947 Added 83.31%
202,308 $9.84 Million
Q4 2021

Feb 14, 2022

BUY
$34.09 - $43.91 $3.44 Million - $4.43 Million
100,902 Added 1066.73%
110,361 $4.71 Million
Q3 2021

Nov 15, 2021

BUY
$25.68 - $38.61 $49,074 - $73,783
1,911 Added 25.32%
9,459 $362,000
Q2 2021

Aug 17, 2021

BUY
$25.96 - $33.44 $195,946 - $252,405
7,548 New
7,548 $213,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.